UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The facial dysmorphy in the newly recognised microdeletion 2p15–p16.1 refined to a 570 kb region in 2p15

Journal of medical genetics, 2008-03, Vol.45 (3), p.189-192

2008

Volltextzugriff (PDF)

Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II

Archives of disease in childhood, 1994-08, Vol.71 (2), p.123-127

1994

Volltextzugriff (PDF)

O16 Piglets as animal model to assess the contribution of fluid therapy to the development of augmented renal clearance in children

Archives of disease in childhood, 2019-06, Vol.104 (6), p.e7-e7

2019

Volltextzugriff (PDF)

P27 The juvenile pig as animal model for unraveling renal drug elimination processes in children

Archives of disease in childhood, 2019-06, Vol.104 (6), p.e28-e28

2019

Volltextzugriff (PDF)

P25 Comparison of renal function estimation methods in critically ill children: a pilot study

Archives of disease in childhood, 2019-06, Vol.104 (6), p.e27-e27

2019

Volltextzugriff (PDF)

P103 Target attainment of amikacin therapy in critically ill children

Archives of disease in childhood, 2019-06, Vol.104 (6), p.e60-e61

2019

Volltextzugriff (PDF)

P99 Clinical validation of published vancomycin population PK models in critically ill neonates

Archives of disease in childhood, 2019-06, Vol.104 (6), p.e58-e59

2019

Volltextzugriff (PDF)

The facial dysmorphy in the newly recognised microdeletion 2p15-p16.1 refined to a 570 kb region in 2p15

Journal of medical genetics, 2008, Vol.45 (3), p.189-192

2008

Volltextzugriff (PDF)

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial

Annals of the rheumatic diseases, 2015-01, Vol.74 (1), p.27-34

2015

Volltextzugriff (PDF)

POS1203 EFFECT OF THE COVID19 PANDEMIC ON RHEUMATOLOGIST PRESCRIPTION BEHAVIOUR OF NEW ADVANCED THERAPY: DATA OF THE TARDIS-RA REGISTRY, A NATIONWIDE BELGIAN BIOLOGIC REGISTRY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.884-884

2021

Volltextzugriff (PDF)

POS1433 IMPACT OF RHEUMATOID ARTHRITIS ON STRESS: A SYSTEMATIC SCOPING REVIEW

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1001-1001

2021

Volltextzugriff (PDF)

AB0109 VALIDATION OF SEPARATE PATIENT-REPORTED, CLINICAL AND LABORATORY FACTOR SCORES AS REPRESENTATION OF DISEASE BURDEN IN A POPULATION WITH ESTABLISHED RHEUMATOID ARTHRITIS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1083-1083

2021

Volltextzugriff (PDF)

POS0694 WHAT TREATMENT GIVES THE BEST CLINICAL RESPONSE AFTER CESSATION OF JAKi THERAPY IN PATIENTS WITH RA? DATA OF THE TARDIS-RA REGISTRY, A NATIONWIDE BELGIAN BIOLOGIC REGISTRY

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.626-627

2022

Volltextzugriff (PDF)

POS0240 WHICH FACTORS DRIVE THE CHOICE BETWEEN A 1ST AND 2ND GENERATION tsDMARD THERAPY IN RA THERAPY?

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.359-359

2022

Volltextzugriff (PDF)

OP0301-HPR Patient Adherence to e-Health Interventions for Remote Disease Monitoring in Chronic Arthritis

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.200-200

2022

Volltextzugriff (PDF)

POS0523 FATIGUE TRAJECTORIES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: A LONGITUDINAL ANALYSIS OF DATA FROM THE CareRA TRIAL

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.520-521

2022

Volltextzugriff (PDF)

POS0207 UNRAVELING THE COMPLEX INTERACTION BETWEEN DISEASE ACTIVITY AND FATIGUE IN EARLY RA: A MEDIATION ANALYSIS WITH DATA FROM THE CareRA TRIAL

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.339-340

2022

Volltextzugriff (PDF)

SAT0028 THE FLARE-RA QUESTIONNAIRE CAN PREDICT FLARES IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS PARTICIPATING IN THE TAPERA TRIAL

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.944-944

2020

Volltextzugriff (PDF)

New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study

Journal of neurology, neurosurgery and psychiatry, 2016-05, Vol.87 (5), p.554-561

2016

Volltextzugriff (PDF)

POS0266-HPR PATIENT-PERCEIVED ASPECTS OF RA FLARE EVOLVE OVER TIME, AS REFLECTED BY THE FLARE-RA QUESTIONNAIRE: POST-HOC ANALYSIS OF TAPERA

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.356-356

2021

Volltextzugriff (PDF)

THU0200 THE CHOICE OF BDMARD OR TSDMARD AS FIRST LINE THERAPY: DATA OF THE TARDIS-RA REGISTRY, A NATIONWIDE BELGIAN BIOLOGIC REGISTRY

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.322-322

2020

Volltextzugriff (PDF)

FRI0022 Rapid and sustained remission contributes to improved psychosocial outcomes after 1 year of treatment in patients with early rheumatoid arthritis: data from the carera trial

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.557

2018

Volltextzugriff (PDF)

OP0032 AN ECONOMIC WINDOW OF OPPORTUNITY FOR PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: 5-YEAR COST-EFFECTIVENESS ANALYSIS OF THE CareRA TRIAL

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.23-24

2022

Volltextzugriff (PDF)

AB1209 A SYSTEMATIC REVIEW ON THE EFFECT OF DMARDS ON FERTILITY IN RHEUMATOID ARTHRITIS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1896-1896

2020

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Journals Archiv - DFG Nationallizenzen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(69)
Berichte
(1)

Sprache

Englisch
(70)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

The facial dysmorphy in the newly recognised microdeletion 2p15–p16.1 refined to a 570 kb region in 2p15

Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II

O16 Piglets as animal model to assess the contribution of fluid therapy to the development of augmented renal clearance in children

P27 The juvenile pig as animal model for unraveling renal drug elimination processes in children

P25 Comparison of renal function estimation methods in critically ill children: a pilot study

P103 Target attainment of amikacin therapy in critically ill children

P99 Clinical validation of published vancomycin population PK models in critically ill neonates

The facial dysmorphy in the newly recognised microdeletion 2p15-p16.1 refined to a 570 kb region in 2p15

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial

POS1203 EFFECT OF THE COVID19 PANDEMIC ON RHEUMATOLOGIST PRESCRIPTION BEHAVIOUR OF NEW ADVANCED THERAPY: DATA OF THE TARDIS-RA REGISTRY, A NATIONWIDE BELGIAN BIOLOGIC REGISTRY

POS1433 IMPACT OF RHEUMATOID ARTHRITIS ON STRESS: A SYSTEMATIC SCOPING REVIEW

AB0109 VALIDATION OF SEPARATE PATIENT-REPORTED, CLINICAL AND LABORATORY FACTOR SCORES AS REPRESENTATION OF DISEASE BURDEN IN A POPULATION WITH ESTABLISHED RHEUMATOID ARTHRITIS

POS0694 WHAT TREATMENT GIVES THE BEST CLINICAL RESPONSE AFTER CESSATION OF JAKi THERAPY IN PATIENTS WITH RA? DATA OF THE TARDIS-RA REGISTRY, A NATIONWIDE BELGIAN BIOLOGIC REGISTRY

POS0240 WHICH FACTORS DRIVE THE CHOICE BETWEEN A 1ST AND 2ND GENERATION tsDMARD THERAPY IN RA THERAPY?

OP0301-HPR Patient Adherence to e-Health Interventions for Remote Disease Monitoring in Chronic Arthritis

POS0523 FATIGUE TRAJECTORIES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: A LONGITUDINAL ANALYSIS OF DATA FROM THE CareRA TRIAL

POS0207 UNRAVELING THE COMPLEX INTERACTION BETWEEN DISEASE ACTIVITY AND FATIGUE IN EARLY RA: A MEDIATION ANALYSIS WITH DATA FROM THE CareRA TRIAL

SAT0028 THE FLARE-RA QUESTIONNAIRE CAN PREDICT FLARES IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS PARTICIPATING IN THE TAPERA TRIAL

New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study

POS0266-HPR PATIENT-PERCEIVED ASPECTS OF RA FLARE EVOLVE OVER TIME, AS REFLECTED BY THE FLARE-RA QUESTIONNAIRE: POST-HOC ANALYSIS OF TAPERA

THU0200 THE CHOICE OF BDMARD OR TSDMARD AS FIRST LINE THERAPY: DATA OF THE TARDIS-RA REGISTRY, A NATIONWIDE BELGIAN BIOLOGIC REGISTRY

FRI0022 Rapid and sustained remission contributes to improved psychosocial outcomes after 1 year of treatment in patients with early rheumatoid arthritis: data from the carera trial

OP0032 AN ECONOMIC WINDOW OF OPPORTUNITY FOR PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: 5-YEAR COST-EFFECTIVENESS ANALYSIS OF THE CareRA TRIAL

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial

AB1209 A SYSTEMATIC REVIEW ON THE EFFECT OF DMARDS ON FERTILITY IN RHEUMATOID ARTHRITIS

Aktive Filter

Suchergebnisse filtern